Pregnancy & Congenital Heart Disease
-
Upload
albert-hutagalung -
Category
Documents
-
view
215 -
download
0
Transcript of Pregnancy & Congenital Heart Disease
-
8/8/2019 Pregnancy & Congenital Heart Disease
1/41
Pregnancy & Congenital HeartDisease (CHD)
Dr. Georges IBRAHIM
08/02/2007
-
8/8/2019 Pregnancy & Congenital Heart Disease
2/41
Incidence of CHD
0.8 % of live births
+ nonstenotic bicuspid aortic valve + mitral valve prolapse
+ PDA in small preterm infants
10 times more often in stillborn babies
Early spontaneous abortions ( many havechromosomal defects )
-
8/8/2019 Pregnancy & Congenital Heart Disease
3/41
Relative incidence at birth
percentageGender >disease
30.5VSD
9.8FASD
9.7FPDA
6.9Pulmonic stenosis
6.8MCoarctation of the Ao
-
8/8/2019 Pregnancy & Congenital Heart Disease
4/41
Relative incidence at birth
6.1MAortic stenosis
5.8Tetralogy of Fallot
4.2MComplete TGA
2.2Persistent truncus A
1.3MTricuspid atresia
16.5
FEbstein`s anomaly
All others
-
8/8/2019 Pregnancy & Congenital Heart Disease
5/41
Incidence of CHD : gender
In toto :
predominate in males
ASD, PDA, Ebstein`s anomaly :
more common in females
-
8/8/2019 Pregnancy & Congenital Heart Disease
6/41
Unoperated, adult survival expectedCommon
Congenital aortic valve disease
Coarctation of the aortaPulmonary valve stenosis
ASD (ostium secundum)
PDA
-
8/8/2019 Pregnancy & Congenital Heart Disease
7/41
Unoperated, adult survival expectedUncommon
Congenital complete heart block
Ebstein`s anomalyCongenitally corrected TGA
Dextrocardia
Sinus of Valsalva aneurysm, coronary arterial fistula, pulmonary
AV fistula
VSD
Fallot`s tetralogy
-
8/8/2019 Pregnancy & Congenital Heart Disease
8/41
Operated, adult survival expected
The same unoperated
Complete TGA (atrial switch operations )
Fontan procedure (& fontan-like operations )
-
8/8/2019 Pregnancy & Congenital Heart Disease
9/41
CV physiology during pregnancy
++++++Blood volume
+++/++++/++++Cardiac output
++/++++++Heart rate
=_=Systolic BP
__ __Diastolic BP
=+++Pulse pressure
_ __ _ __SVR
-
8/8/2019 Pregnancy & Congenital Heart Disease
10/41
Maternal outcome
Is determined by :
--nature of disease & surgical repair
-- cyanosis & Hb
-- PVR
-- functional capacity
CVdeterioration favorised by :
- exercise, heat, numidity, anemia, infections, and arrhythmias
-
8/8/2019 Pregnancy & Congenital Heart Disease
11/41
Maternal outcome
in general :
- good in most non-cyanoticcases
- unfavorable if cyanosis
impaired functional status
( CHF, arrhythmias, hypertension, angina, IE and
thromboembolic )
-
8/8/2019 Pregnancy & Congenital Heart Disease
12/41
CHD - Fetal outcome
Is determined by maternal
-- cyanosis-- functional capacity
Fetal wastages (20% noncy vs 45% cy )
Low birth w.& prematurity (correlate with Hb )
CHD ( 10 % ) ( VSD: 22%, AS: 20% , Fallot: 3-17%)
Other physical & mental abnormalities
-
8/8/2019 Pregnancy & Congenital Heart Disease
13/41
Tolerance of pregnancy in CHD
POORLYINTERWELL
NYHA IVNYHA II-IIINYHA I
R-L shunt,
Unrepaired cyan
Ebstein`s
anomaly
L-R shunt - PH
PHT/ P vascular
disease
Repaired TGA
Fontan repair
Repaired TF
-
8/8/2019 Pregnancy & Congenital Heart Disease
14/41
Tolerance of pregnancy in CHD
PS (severe) ?PS (mild to
moderate)
Marfan`s
CoarctationAo
PR,TR (evensevere if low
pressure)
AS, MS (severe)AS, MS(moderate)
AR, MR (mild tomoderate)
-
8/8/2019 Pregnancy & Congenital Heart Disease
15/41
ASD ( ostium secundum )
Majority female, reproductive life
Tolerate well usually(PHT rare in childbearing age )
Paradoxical embolus
Acute blood loss increase L-R shunt
Postop :
- atrial arrhythmias & mitral regurgitation(if repair after young adulthood)
-
8/8/2019 Pregnancy & Congenital Heart Disease
16/41
PDA
Mild & moderate-sized :- risk ofIEduring delivery
Moderately restrictive :- decrease in SVRdecrease L-Rshunt
shunt reversal if PHT
- risk of HF(> Age 30 )
Non restrictive (+ PV disease & R-L shunt) :- decrease in SVR increase R-L shunt(lower uterine oxygen saturation potential harm to the
fetus)
-
8/8/2019 Pregnancy & Congenital Heart Disease
17/41
PDA post-op
No risk ofIE six months after division
Large PDA :
- depends on residua (PVR)
(LV function )
-
8/8/2019 Pregnancy & Congenital Heart Disease
18/41
Isolated PS
Well tolerated ( even severe occasionally )
IE prophylaxis advisable
Severe PS :- Should be corrected prior to conception
- Balloon dilatation during pregnancy efficacious
( progressive RV failure despite drug therapy )
Post-op :- Low risk ofIE
- Mild to moderate PR not a concern
-
8/8/2019 Pregnancy & Congenital Heart Disease
19/41
Coarctation of the aorta
Hypertension (comparatively low incidence of toxemia )
Increased risk ofaortic rupture ordissection
Increased risk ofcerebralhemorrhage
LVFexceptional under age 40 (except infants)
Risk ofIE if bicuspid aortic valve
angina
To be corrected prior to pregnancy
Limiting physical activity & controlling BP
Surgical correction during pregnancy successful
(severe uncontrolable hypertension orCHF )
-
8/8/2019 Pregnancy & Congenital Heart Disease
20/41
Coarctation post-op
Risk of pregnancy depends on :- relief of the isthmic obstruction
- reduction of systemic BP
- surgical technique
- presence of bicuspid AV
Risk of gestational rupture of aneurysm of circle ofWillis ?
Procedure of choice : resection & end-to-end
anastomosis
-
8/8/2019 Pregnancy & Congenital Heart Disease
21/41
Congenital aortic valve disease(Bicuspid aortic valve)
Low incidence among women, cardiac defects in 20% of infants
Stenosis : mild to moderate generally well toleratedsevere (+ dyspnea, angina) high risk
Regurg : generally well tolerated even severe(provided good LV function )
High risk ofIE : prophylaxis during labor & delivery
Risk of aortic root dissection (bicuspid )
-
8/8/2019 Pregnancy & Congenital Heart Disease
22/41
Congenital aortic valve disease
Severe AS :
balloon dilatation (provided thin, mobile& not calcified )Mild to moderate AS & significant AR :
advice pregnancy before replacement (provided good LVfunction )
Severe AS and\or AR (replacement indicated ) : advice a tissue valve
Post-op : risk ofIE and aortic root dissection persist
-
8/8/2019 Pregnancy & Congenital Heart Disease
23/41
Congenital aortic valve disease
Severe aortic stenosis (pregnant patient) :(high risk of decompensation in the 2nd or3rd trimester)
early abortion :+ valvuloplasty or replacement
continuation of pregnancy :+
medicaltreatment, hemodynamic monitoring during laborand delivery and appropriate anesthesia
+balloon valvuloplasty or
+surgicalreplacement
-
8/8/2019 Pregnancy & Congenital Heart Disease
24/41
Fallot`s tetralogy
Pregnancy :
- exacerbate R-to-L shunt and cyanosis.
poor prognostic signs : HTC> 60%, SaO2
-
8/8/2019 Pregnancy & Congenital Heart Disease
25/41
Fallot`s tetralogy
to be corrected and revised if partially
repaired prior to pregnancy (outcome markedlyimproved by surgical repair )
Post-op :
- small risk especially ifRVoutflow obstructionis relieved without significant PR.
- post-op electrophysiological sequlae
infrequent if repair at a young age
-
8/8/2019 Pregnancy & Congenital Heart Disease
26/41
Ebstein`s anomaly of the TV
RVF : IncreasedCO
Atrial tachyarrhythmias : one-third of nonpregnant
(rapid ventricular rate in response to AF or flutter)
Paradoxical emboli and hypoxemia :IncreasedR-Lshunt byIncrease in RV filling pressure
Risk of IE
*** Outcome depends on severity of TR, RVF, and cyanosis
*** successful pregnancy reported in the majority ofpatients
-
8/8/2019 Pregnancy & Congenital Heart Disease
27/41
Ebstein`s anomaly post-op
Surgery :
improve RV functioneliminate the risk of paradoxical emboli &
bypass tracts
reduce the risk ofIE& supraVarrhythmias
-
8/8/2019 Pregnancy & Congenital Heart Disease
28/41
VSD
Isolated : well tolerated
(risk ofIE)(some CHF & arrhythmias reported )
With PHT :
(marked reduction in BPshunt reversal )
Post-op :
(electrophysiological sequelae exceptional )
(offspring : 22% CHD, 50% of them VSD )
-
8/8/2019 Pregnancy & Congenital Heart Disease
29/41
Congenital complete heart block
Uncommon
Asymptomatic : uneventful pregnancy
(provided QRS not prolonged & satisfactory rateresponse to exercise )
Stokes-Adams attacks : occasionally occur duringpregnancy
Post-op ( occasionally ) :- dual-chamber PMpreferable
-
8/8/2019 Pregnancy & Congenital Heart Disease
30/41
Marfan`s syndrome
High maternal morbidity
Inheritance 50%
Majority : CV manifestation during pregnancy (AR, HF,Ao dissection)
Aortic root < 40 mm :In general, favorable outcomePeriodic follow up, prophylactic beta blockers
(recommended) & limitedphysicalactivity
Preconception counseling : Dilatation of the aorta
advise against conceptionduring pregnancy : Significant aortic dilatation
therapeuticabortion
surgicalintervention
During delivery : Significant cardiac complicationabdominaldelivery
-
8/8/2019 Pregnancy & Congenital Heart Disease
31/41
Eisenmengers syndrome
high risk for maternalmorbidity and
mortality ( mort 38% ).
poor fetaloutcome.
( fetal loss, prematurity, itrauterine growth retardation, and
perinatal death )
to be advised against pregnancy,
abortion indicated.
-
8/8/2019 Pregnancy & Congenital Heart Disease
32/41
Eisenmengers syndrome
If a patient decide to proceed to term :
- Close follow-up
- Restriction of physical activity
-Anticoagulation
- Hospitalization for any sign of premature uterine activity
- Early elective hospitalization recommended
- Spontaneous laborpreferred to induction
- BP, ECG, blood gas monitoring essential
- High concentration O2 may be helpful
- Vaginal delivery most tolerate (+ forceps & vacuum extraction)
- Cesarean section (GA with minimal negative inotropic orsegmental epidural )
-
8/8/2019 Pregnancy & Congenital Heart Disease
33/41
Complex cyanotic CHD
Cyanosis before surgeryabnormalities of gynecological
endocrinology that may influence fertility
high riskif uncorrected or partially
corrected.
Hb andSaO2best predictors for fetal
outcome.
pregnancy discouraged, early
interruption indicated.
-
8/8/2019 Pregnancy & Congenital Heart Disease
34/41
Complex cyanotic CHD - postop
Successful Fontan repairadequate
homodynamic reserve(if good ventricular function but other variables mayinfluence outcome; atrial arrhythmias, thromboembolic,, )
Postop cTGA late postop sequellae the rule( electrophysiological sequellae, RV progressive systolicdysfunction & AR )
-
8/8/2019 Pregnancy & Congenital Heart Disease
35/41
Should not become pregnant
* Cyanotic CHD
* Pulmonary hypertension* Marfan`s syndrome
-
8/8/2019 Pregnancy & Congenital Heart Disease
36/41
Prenatal care
Anxiety
Diuretics :judiciously for HF
Exercise : moderate isotonic
Dry & cool atmosphere therapeutic
Pathological anemia addressed
Meticulous leg care
Passive standing avoidedSupine position minimized
Oxygen administration open to question
Anticoagulation at least 2rd tri & 1 monthspp in high risk
-
8/8/2019 Pregnancy & Congenital Heart Disease
37/41
Labor & deliverymild unoperated & successfully operated
The same as for normal pregnant
IE prophylaxis :
Routine delivery recommended( low incidence ofbactremia in uncomplicated vaginal delivery )
Episiotomy & vacuum extraction indicated
(from the onset of labor through the 3rd or 4th postpartal day)
-
8/8/2019 Pregnancy & Congenital Heart Disease
38/41
Labor & deliveryfunctionally important CHD
Induced vaginal delivery :- (+ forceps & vacuum 2nd stage )
Cesarean section :- obstetrical reasons
- preterm women on coumadin
- deteriorating maternal status
( about twice the blood loss as vaginal delivery
& risks of wound and uterine infection,
thrombophlebitis and potential postoperative
complications )
-
8/8/2019 Pregnancy & Congenital Heart Disease
39/41
Labor & deliveryfunctionally important CHD
Antibiotic prophylaxis
O2 therapyHemodynamic & blood gas monitoring
( strongly recommended )
hypotension avoided (increasing R-L shunt)
regional anesthesia with caution( recommended : inhalation a, nerve blocks, intrathecal
morphine )
-
8/8/2019 Pregnancy & Congenital Heart Disease
40/41
Contraception
Barrier methods (condoms, diaphragm withspermicides )
Tubal ligation : safe even in high risk
Levonorgestrel implants : safe & efficacious , fluidretention modest
Low estrin : safe & nonthrombogenic
IUD : low risk ofIE, but induce excessive bleeding
Progestin injections : not recommended if HF, fluidretention
-
8/8/2019 Pregnancy & Congenital Heart Disease
41/41
Thank youThank you